These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 20507694)
1. Blood-stage malaria vaccines - recent progress and future challenges. Goodman AL; Draper SJ Ann Trop Med Parasitol; 2010 Apr; 104(3):189-211. PubMed ID: 20507694 [TBL] [Abstract][Full Text] [Related]
2. Prospects for Malaria Vaccines: Pre-Erythrocytic Stages, Blood Stages, and Transmission-Blocking Stages. Zheng J; Pan H; Gu Y; Zuo X; Ran N; Yuan Y; Zhang C; Wang F Biomed Res Int; 2019; 2019():9751471. PubMed ID: 31687404 [TBL] [Abstract][Full Text] [Related]
3. The march toward malaria vaccines. Hoffman SL; Vekemans J; Richie TL; Duffy PE Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116 [TBL] [Abstract][Full Text] [Related]
4. Blood stage vaccines for Plasmodium falciparum: current status and the way forward. Ellis RD; Sagara I; Doumbo O; Wu Y Hum Vaccin; 2010 Aug; 6(8):627-34. PubMed ID: 20519960 [TBL] [Abstract][Full Text] [Related]
5. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study. Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398 [TBL] [Abstract][Full Text] [Related]
6. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target. Ragotte RJ; Higgins MK; Draper SJ Trends Parasitol; 2020 Jun; 36(6):545-559. PubMed ID: 32359873 [TBL] [Abstract][Full Text] [Related]
7. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens. Bettencourt P Front Immunol; 2020; 11():190. PubMed ID: 32153565 [No Abstract] [Full Text] [Related]
8. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine. Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267 [TBL] [Abstract][Full Text] [Related]
9. The development of a multivalent DNA vaccine for malaria. Hedstrom RC; Doolan DL; Wang R; Gardner MJ; Kumar A; Sedegah M; Gramzinski RA; Sacci JB; Charoenvit Y; Weiss WR; Margalith M; Norman JA; Hobart P; Hoffman SL Springer Semin Immunopathol; 1997; 19(2):147-59. PubMed ID: 9406343 [No Abstract] [Full Text] [Related]
10. Progress in the development of recombinant and synthetic blood-stage malaria vaccines. Mahanty S; Saul A; Miller LH J Exp Biol; 2003 Nov; 206(Pt 21):3781-8. PubMed ID: 14506213 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys. Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW Malar J; 2016 Mar; 15():159. PubMed ID: 26975721 [TBL] [Abstract][Full Text] [Related]
12. Vaccines against malaria. Hill AV Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2806-14. PubMed ID: 21893544 [TBL] [Abstract][Full Text] [Related]
13. The naturally acquired immunity in severe malaria and its implication for a PfEMP-1 based vaccine. Chen Q Microbes Infect; 2007 May; 9(6):777-83. PubMed ID: 17398133 [TBL] [Abstract][Full Text] [Related]
14. Antigens for pre-erythrocytic malaria vaccines: building on success. Speake C; Duffy PE Parasite Immunol; 2009 Sep; 31(9):539-46. PubMed ID: 19691557 [TBL] [Abstract][Full Text] [Related]
15. Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine. Kurtis JD; Hollingdale MR; Luty AJ; Lanar DE; Krzych U; Duffy PE Trends Parasitol; 2001 May; 17(5):219-23. PubMed ID: 11323304 [TBL] [Abstract][Full Text] [Related]